Middle East News Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Journal.

Press releases published on April 13, 2026

Apr. 13, 2026

ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer

Indeterminate GlobeNewswire

Apr. 13, 2026

Inspira Begins AME Technology Implementation Process with One of the World's 10 Largest U.S. Based Companies

Indeterminate GlobeNewswire

Apr. 13, 2026

Nanox Signs Distribution Agreement with Digital X-Ray Imaging to Expand Nanox.ARC Adoption in Arkansas

Indeterminate GlobeNewswire

Apr. 13, 2026

ImPact Biotech Presents Preliminary Data from Phase 1 Study of Padeliporfin VTP in LA-PDAC at SIR 2026 and Provides Strategic Business Update

Indeterminate GlobeNewswire

Apr. 13, 2026

BrainsWay to Participate in the 25th Annual Needham Virtual Healthcare Conference

Indeterminate GlobeNewswire

Apr. 13, 2026

Septerna Announces Initiation of Phase 1 Clinical Trial of SEP-479, an Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism

Indeterminate GlobeNewswire

Apr. 13, 2026

Global Uranium Corp. Announces Completion of Geological Mapping at the Airline Project in Wyoming

Indeterminate GlobeNewswire

Apr. 13, 2026

Favorable Results of Ovarian Cancer Study Presented at Annual Society of Gynecological Care Conference

Indeterminate GlobeNewswire

Apr. 13, 2026

Praxis to Showcase Essential3, the First Positive Phase 3 Program in Essential Tremor, at AAN 2026

Indeterminate GlobeNewswire

Apr. 13, 2026

Daraxonrasib Demonstrates Unprecedented Overall Survival Benefit in Pivotal Phase 3 RASolute 302 Clinical Trial in Patients with Metastatic Pancreatic Cancer

Indeterminate GlobeNewswire

Apr. 13, 2026

ParaZero Secures a Follow-on Order for DefendAir Counter-UAS, Including Personal Net Launchers, Net Pods, and Training

Indeterminate GlobeNewswire

Apr. 13, 2026

NervGen Pharma to Participate in the H.C. Wainwright "HCW@Home" Series and the 2026 Bloom Burton & Co. Healthcare Investor Conference

Indeterminate GlobeNewswire

Apr. 13, 2026

DEEP SEA MINERALS CORP. APPOINTS DAN MCCONNELL AS VICE PRESIDENT OF EXPLORATION

Indeterminate GlobeNewswire

Apr. 13, 2026

Allogene Therapeutics Reports Interim Futility Analysis from Pivotal ALPHA3 Trial Showing 58.3% MRD Clearance with Cemacabtagene Ansegedleucel (Cema-Cel) vs. 16.7% in Observation Arm in First-Line Consolidation LBCL

Indeterminate GlobeNewswire

Apr. 13, 2026

Fredonia Mining Inc. Grants Stock Options and Formalizes Management Agreements

Indeterminate GlobeNewswire

Apr. 13, 2026

Newly Published U.S. Expert Consensus Aligns with MediWound’s Strategy for Chronic Wound Debridement

Indeterminate GlobeNewswire

Apr. 13, 2026

Gelatide Drops Investigated (2026 Report) What Consumers Should Verify Before Buying

Indeterminate GlobeNewswire

Apr. 13, 2026

Eclipse Life Sciences Completes Enrollment in Phase 2 Study Evaluating EC-104 for Diabetic Macular Edema (DME)

Indeterminate GlobeNewswire

Apr. 13, 2026

Ocular Therapeutix™ Announces Additional Positive Week 52 Data from Landmark SOL-1 Phase 3 Trial of AXPAXLI™ in Wet AMD

Indeterminate GlobeNewswire

Apr. 13, 2026

GFG Exercises its Option and Earns 100% in the 6,500-Hectare WWCC Property in the Prolific Timmins Gold District

Indeterminate GlobeNewswire